| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 7 | |
| #2 | United States | 6 | |
| #3 | Hungary | 2 | |
| #4 | Serbia | 2 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | Chile | 1 | |
| #8 | Ecuador | 1 | |
| #9 | Peru | 1 | |
| #10 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Heterocyclic compounds | |
| #3 | Therapeutic chemical compounds | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kym Philip R | 19 |
| #2 | Wang Xueqing | 19 |
| #3 | Altenbach Robert J | 17 |
| #4 | Van Der Plas Steven Emiel | 17 |
| #5 | Bogdan Andrew | 17 |
| #6 | Searle Xenia B | 15 |
| #7 | Liu Bo | 15 |
| #8 | Yeung Ming C | 15 |
| #9 | Desroy Nicolas | 14 |
| #10 | Gfesser Gregory A | 14 |
| Publication | Filing date | Title |
|---|---|---|
| EP3747882A1 | Prodrug modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use | |
| US2019077784A1 | Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use |